NBY (STOCKS)
NovaBay Pharmaceuticals, Inc.
$0.580000
-0.082000 (-12.39%)
Prev close: $0.662000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael Kazley
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $76.23M
- Employees
- 14
- P/E (TTM)
- -0.39
- P/B (TTM)
- -1.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.83M |
| Benefits Costs and Expenses | $3.63M |
| Cost Of Revenue | $3.78M |
| Costs And Expenses | $10.59M |
| Gross Profit | $6.52M |
| Operating Expenses | $13.19M |
| Operating Income/Loss | -$6.67M |
| Income/Loss From Continuing Operations After Tax | -$6.99M |
| Income/Loss From Continuing Operations Before Tax | -$6.79M |
| Income/Loss From Discontinued Operations Net Of Tax | $10.12M |
| Income Tax Expense/Benefit | $400.00K |
| Net Income/Loss | $3.13M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$111.00K |
| Net Income/Loss Attributable To Parent | $3.24M |
| Net Income/Loss Available To Common Stockholders, Basic | $3.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.21 |
| Basic Average Shares | 8,135,000 |
| Assets | $3.49M |
| Current Assets | $2.90M |
| Noncurrent Assets | $589.00K |
| Fixed Assets | $6.00K |
| Other Non-current Assets | $583.00K |
| Liabilities | $1.85M |
| Current Liabilities | $1.45M |
| Accounts Payable | $76.00K |
| Wages | $450.00K |
| Other Current Liabilities | $922.00K |
| Noncurrent Liabilities | $405.00K |
| Equity | $1.11M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.11M |
| Liabilities And Equity | $3.49M |
| Net Cash Flow From Operating Activities | -$5.52M |
| Net Cash Flow From Operating Activities, Continuing | -$5.52M |
| Net Cash Flow From Investing Activities | $10.42M |
| Net Cash Flow From Investing Activities, Continuing | $10.42M |
| Net Cash Flow From Financing Activities | -$2.70M |
| Net Cash Flow From Financing Activities, Continuing | -$2.70M |
| Net Cash Flow | $2.21M |
| Net Cash Flow, Continuing | $2.21M |
| Comprehensive Income/Loss | $3.13M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $3.13M |
| Other Comprehensive Income/Loss | $0.00 |